SEC Files Charges Over Alleged MMJ Investment Scam
Wall Street regulators filed civil fraud charges against a company and four people allegedly caught up in a…
News May 27
Latest In: Stocks
Week in Review: OH Lawmakers Okay MMJ, Nasdaq says No to MassRoots & MMJ for Vets
By John Schroyer and Omar Sacirbey Ohio lawmakers pass a medical marijuana bill in a bid to undercut…
News May 27Nasdaq shoots down MassRoots for stock listing
Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq,…
News May 24FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25AmeriCann Invests $6.7M in Massachusetts MJ Facilities
AmeriCann, a Denver medical marijuana company, is investing nearly $7Â million in a dispensary and a grow facility in…
News April 14MassRoots Taking Another Stab at Nasdaq Listing
MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.…
News April 11
GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry
By Omar Sacirbey A British company that develops cannabis-based medicine is on the verge of a major breakthrough…
News March 30Hustler Publisher Invests in Ancillary MMJ Company
The cannabis industry is attracting investors from all walks of life. Including porn. Larry Flynt, the famed publisher…
News March 25Study Results Send GW Pharma’s Stock Soaring
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine…
News March 14
Oakland Dispensary Shares To Be Publicly Traded
By Omar Sacirbey Following a brutal 2015 for marijuana stocks, the cannabis investment sector has something to smile…
News January 13
Latest Sponsored
